EP3129367
2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.4.2015EP published:
4.9.2019EP application number:
15716690.1
EPO information:
European Patent Register
Max expiry date:
1.4.2035
Title:
2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS
Timeline
Today
2.4.2015EP application
4.9.2019EP Publication
Owner
Name:
Rigel Pharmaceuticals, Inc.Address:
1180 Veterans Boulevard, 94080, South San Francisco, CA, US
Inventor
Name:
SINGH, RajinderAddress:
Belmont, CA, US
Name:
BHAMIDIPATI, SomasekharAddress:
Foster City, CA, US
Name:
DING, PingyuAddress:
Foster City, CA, US
Name:
PAYAN, DonaldAddress:
Hillsborough, CA, US
Name:
GELMAN, MarinaAddress:
San Francisco, CA, US
Name:
KINSELLA, ToddAddress:
Redwood City, CA, US
Priority
Number:
201461976880 PDate:
8.4.2014Country:
US
Number:
201462019577 PDate:
1.7.2014Country:
US
Classification
Categories:
C07D 401/14, C07D 401/04, C07D 417/04, C07D 417/14, C07D 471/04, C07D 487/04, A61K 31/4427, A61P 35/00